NICE recommends statins for everyone who has chronic kidney disease

Healthcare professionals should offer statins to people with chronic kidney disease, NICE says.

NICE says that statins will help those who suffer with chronic kidney disease to manage their increased risk of cardiovascular disease (CVD).

The new NICE standard lists Atorvastatin as the preferred statin to offer patients because it is both clinically and cost effective.

Research has shown that there is a connection between reduced kidney function and CVD. Around 2.6 million people in England have chronic kidney disease and approximately 60,000 people die prematurely each year because of the disease.

Gillian Leng, deputy chief executive at NICE, said: “We know that a high number of people with long-term kidney problems will develop cardiovascular disease. This means they have an increased risk of suffering a fatal heart attack or stroke.

“It is important for healthcare professionals to speak to patients about their treatment options. The effectiveness of statins is now well proven, as is their long term safety. They may appeal to a lot of people who are at risk.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho